))
Latest Developments Regarding Controlled Substance Issues in Telemedicine
Manage episode 431331834 series 3528724
Konten disediakan oleh Ropes & Gray LLP and Gray LLP. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Ropes & Gray LLP and Gray LLP atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
On this episode of Ropes & Gray’s podcast series, Controlling Opinions, hear from partners Brett Friedman, Andrew O’Connor, and Josh Oyster regarding recent developments related to the prescribing of controlled substances via telemedicine. They discuss the current DEA regulatory landscape related to prescriptions of controlled substances via telemedicine and explore the implications of a recently announced prosecution in which the Department of Justice alleged that executives at a digital health company wrongfully distributed controlled substances via telemedicine.
3 episode
Bagikan
